Mouse models of Alzheimer's disease: A quest for plaques and tangles

ILAR Journal

Volumn 43, Issue 2, 2002, Pages 89-99

  Richardson, James A ^a   Burns, Dennis K ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Alzheimer's disease; Amyloid plaque; Fibrillary tangle; Neuro; Tau; Transgenic mice

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ANIMAL DISEASE; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MOUSE; NEUROFIBRILLARY TANGLE; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SENILE PLAQUE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; NEUROFIBRILLARY TANGLES; SENILE PLAQUES; TAU PROTEINS;

EID: 0036372112     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.43.2.89     Document Type: Article

References (63)

1. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope GE, Diamond DM. 2001. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891:42-53.
2. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM. 1997. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet 17:263-264.
3. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang I, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert. Schenk D, Yednock T. 2000. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat Med 6:916-919.
4. Borchelt DR, Ratovitski, T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS. 1997. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19:939-945.
5. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS. 1996. Familial Alzheimer's disease-linked presenilin I variants elevate Abetal-42/1-40 ratio in vitro and in vivo. Neuron 17:1005-1013.
6. Bornemann KD, Staufenbiel M. 2000. Transgenic mouse models of Alzheimer's disease. Ann NY Acad Sci 908:260-266.
7. Brion JP, Tremp G, Octave JN. 1999. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylalion as in the pretangle stage of Alzheimer's disease. Am J Pathol 154:255-270.
8. Buxbaum JD, Thinakaran G, Koliatsos V, O'Callahan J, Slunt HH, Price DL, Sisodia. SS. 1998. Alzheimer amyloid protein precursor in the rat hippocampus: Transport and processing through the perforant path. J Neurosci 18:9629-9637.
9. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat Neurosci 4:233-234.
10. Cao X, Sudhof TC. 2001. A transcriptively active complex of app with fe65 and histone acetyltransferase tip60. Science 293:115-120.
11. Citron M, Westaway D, Xia W, Carlson G, Diehi T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George-Hyslop P, Selkoe DJ. 1997. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3:67-72.
12. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F. 1998. Deficiency of preseniIin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387-390.
13. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. 1996. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713.
14. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Choc H. 2000. BACE2, a β-sccretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein. Proc Natl Acad Sci U S A 97:9712-9717.
15. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagoplan S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masllah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Pennlman E, Power M, Shenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527.
16. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-713.
17. Goedert M, Hasegawa M. 1999. The tauopathies: Toward an experimental animal model. Am J Pathol 154:1-6.
18. Gotz J, Chen F, van Dorpe J, Nitsch RM. 2001. Formation of neurofibrillary tangles of P301L tau transgenic mice induced by Aβ42 fibrils. Science 293:1491-1495.
19. Gotz J, Probst A, Spillantini MG, Schafer T, Jakes R, Burki K, Goedert M. 1995. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. Embo J 14:1304-1313.
20. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin I transgenes. Nat Med 4:97-100.
21. Hsiao KK, Borchelt DR, Olson K, Johanrisdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark HB, Carlson G. 1995. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15:1203-1218.
22. Hsiao K, Chapman P, Nilsen S, Eckmnan C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
23. Hutton M, Lendon L, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Varen J, Hillebrand M, Joosse M, Kwon, JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Naystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, van Swieten J, Mann D, Lynch T, Heutink P. 1998. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705.
24. Hyman BT, Trojanowski JQ. 1997. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease. J Neuopathol Exp Neurol 56:1095-1097.
25. Irizarry MC, Cheurig BS, Rebeck GW, Paul SM, Bales KR, Hyman BT. 2000. Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V7I7F) transgenic mice. Acta Neuropathol (Berl) 100:451-458.
26. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. 1997a. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 56:965-973.
27. Irizarry MC, Soriano F, McNamara M, Page KJ, Schenk D, Games D, Hyman BT. 1997b. A-beta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 17:7053-7059.
28. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski Q, Lee VM. 1999. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 24:751-762.
29. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM. 2001. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 158:555-562.
30. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC. 2001. Metabolic regulation of brain A-beta by neprilysin. Science 292:1550-1552.
31. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang S Y, Schmidt D, Chishti MA Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D. 2000. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408:979-982.
32. Kuo YM, Crawford F, Mullan M, Kokjohn TA, Emmerling MR, Weller RO, Roher AE. 2000. Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease. Mol Med 6:430-439.
33. Kuo YM, Kokjohn, TA, Beach TG, Sue LI, Brune D, Lopez JC, Kalback, WM, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Roher AE. 2001. Comparative analysis of amyloid-β chemical structure and amyloid plaque morphlogy of transgenic mouse and Alzheimer's disease brains. J Biol Chem 276:12991-12998.
34. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G. 1995. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 9:21-30.
35. Lewis J, Dickson, DW, Lin W-L, Chisholm L, Corral A, Jones G, Yen S-H, Sahara N, Skipper L, Yager D, Echman C, Hardy J, Hutton M, McGowan E. 2001. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487-1491.
36. Lewis J, McGowan E, Rockwood J, Melrose H, Nachamaju P, Van Slegtenhorst M, Gwinn-Hardy K, Murphy MP, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M, Nasir J, Floresco SB, O'Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR. 2000. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402-405.
37. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R. 2001. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4:231-232.
38. Mandelkow EM, Mandelkow F. 1998. Tau in Alzheimer's disease. Trends Cell Biol 8:425-427.
39. Masliah E, Rockenstein E, Veinbergs I, Yutaka S, Mallory M, Hashimoto M, Mucke L. 2001. β-Amyloid peptides enhance a-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A 98: 12245-12250.
40. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. 1996. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 16:5795-5811.
41. Moran PM, Higgins LS, Cordell B, Moser PC. 1995. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc Natl Acad Sci U S A 92:5341-5345.
42. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. 2000. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985.
43. Neve RL, Boyce FM, McPhie DL, Greenan J, Oster-Granite ML. 1996. Transgenic mice expressing APP-C100 in the brain. Neurobiol Aging 17:191-203.
44. Oster-Granite ML, McPhie DL, Greenan J, Neve RL. 1996. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci 16:6732-6741.
45. Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME, Yu H, Chen HY, Van de Ploeg LH, Zheng H. 1998. Mutant human presenilin I protects presenilin I null mouse against embryonic lethality and elevates Abeta 1-42/43 expression. Neuron 20:611-617.
46. Quon D, Wang Y, Catalano R , Scardina JM, Murakami K, Cordell B. 1991. Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352:239-241.
47. Schenk D, Barbour R, Dünn W, Gordon G, Grajeda H, Guido T, Hu K, Huang, J, Johnson-Wood K, Khan K, Kholodenko D, Lee Z, Liao M, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. 1999. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177.
48. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M , Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S. 1996. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870.
49. Selkoe DJ. 1998. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453.
50. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S. 1997. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89:629-639.
51. Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo, S, Kiyama H, Iwata H, Tomita T, Iwatsubo T,m Saido TC. 2001. Neprilysin degrades both amyloid-β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276:21895-21901.
52. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D Seubert P, Suomensaari SM, Wang S, Walker D, Zhao J, McConlogue L, Varghese J. 1999. Purification and cloning of amyloid precursor protein bera-secretase from human brain. Nature 402:537-540.
53. Strittmatter WJ. 2000. Apolipoprotein E and Alzheimer's disease. Ann N Y Acad Sci 924:91-92.
54. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR. 1997. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A 94:13287-13292.
55. Sturchler-Pierrat C, Staufenbiel M. 2000. Pathogenic mechanisnis of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci 920:134-139.
56. Takaki Y, Iwata N, Tsubuki S, Taniguchi S, Toyoshima S, Lu B, Gerard NP, Gerard C, Lee HJ, Shirotani K, Saido TC. 2000. Biochemical identification of the neutral endopeptidase family member responsible for the catabolism of amylid beta peptide in the brain. J Biochem 128:897-902.
57. Tesseur I, Van Dorpe J, Bruynseels K, Bronfman F, Sciot, R, Van Lommel A, Van Leuven F. 2000a. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol 157:1495-1510.
58. Tesseur I, Van Dorpe J, Spittaels K, Van den Haute C, Moechars D, Van Leuven F. 2000b. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol 156:951-964.
59. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. 1999. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741.
60. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ. 2000. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-1665.
61. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC , Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME. 1999. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402:533-537.
62. Yasojima K, Akiyama H, McGeer EG, McGeer PL. 2001. Reduced neprilysin in high plaque areas of Alzheimer brain: A possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297: 97-100.
63. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S. Conner MW, Stevens KA, Slunt HH, Sisodia SS, Chen HY, Van der Ploeg LH. 1995. Beta-amyloid precursor protein-deficient mice reveal reactive gliosis and decreased locomotor activity. Cell 81:525-531.